Ze-Fei Jiang - Concepedia

Author

Ze-Fei Jiang

307th Hospital of Chinese People’s Liberation Army

Also Known As

Ze-Fei Jiang, Ze-fei Jiang, Ze‐fei Jiang

Publications

467

Citations

H-Index

Concepts

All Affiliations

307th Hospital of Chinese People’s Liberation Army Chinese Academy of Medical Sciences & Peking Union Medical College Zhejiang Cancer Hospital Fudan University Shanghai Cancer Center Third Affiliated Hospital of Harbin Medical University

About

Ze-Fei Jiang is an author at 307th Hospital of Chinese People’s Liberation Army specializing in cancer therapeutics, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	408
2	Pharmacology	3	3	359
3	Health Sciences	2	2	76
4	Nursing	1	1	49
5	Pathology	1	1	53

Ze-Fei Jiang

Publications

463

Citations

H-Index

Page 1

	Year	Citations
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial Xi-Chun Hu, Jian Zhang, Bing-He Xu, The Lancet Oncology First-line TherapyBreast OncologyOncologyGemcitabine Versus PaclitaxelPharmacology	2015	279
Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro Jianming Xu, San‐tai Song, Zhong‐ming Tang, Breast Cancer Research and Treatment Predictive ChemotherapyAdvanced Breast CancerBreast OncologyMedicinePharmacology	1999	53
A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer Ke‐Da Yu, Ying Zhou, Guang‐Yu Liu, Breast Cancer Research and Treatment NursingBreast OncologyMedicineAromatase Inhibitor MedicationCancer Management	2012	49
Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients Bing-He Xu, Ze-Fei Jiang, Daniel T. T. Chua, Chinese Journal of Cancer	2011	43
Pegylated filgrastim is comparable with filgrastim as support for commonly used chemotherapy regimens Yuan-Kai Shi, Qiang Chen, Yun-Zhong Zhu, Anti-Cancer Drugs PharmacotherapySafety ParametersMetronomic ChemotherapyCancer ChemotherapyHematological Malignancy	2013	27
Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial Jian-Wei Li, Guang‐Yu Liu, Ya-jie Ji, Cancer Management and Research	2018	12

Page 1